HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Judah Folkman Selected Research
Judah Folkman Research Topics
Disease
63
Neoplasms (Cancer)
06/2012 - 02/2002
7
Endometriosis
04/2011 - 01/2005
7
Neoplasm Metastasis (Metastasis)
09/2010 - 10/2002
4
Hypoxia (Hypoxemia)
05/2010 - 09/2003
3
Breast Neoplasms (Breast Cancer)
05/2012 - 01/2004
3
Melanoma (Melanoma, Malignant)
05/2012 - 02/2008
3
Neuroblastoma
02/2012 - 10/2007
3
Pancreatic Neoplasms (Pancreatic Cancer)
06/2011 - 01/2003
3
Glioblastoma (Glioblastoma Multiforme)
09/2010 - 05/2008
3
Lewis Lung Carcinoma
09/2010 - 05/2005
3
Pathologic Neovascularization
06/2010 - 03/2006
3
Disease Progression
03/2009 - 07/2005
3
Inflammation (Inflammations)
01/2008 - 03/2005
2
Type 2 Diabetes Mellitus (MODY)
09/2013 - 10/2002
2
Macular Edema
09/2013 - 10/2010
2
Colonic Neoplasms (Colon Cancer)
06/2012 - 07/2004
2
Diabetic Retinopathy (Retinopathy, Diabetic)
10/2010 - 06/2008
2
Corneal Neovascularization
09/2010 - 01/2008
2
Liposarcoma
04/2010 - 05/2006
2
Down Syndrome (Down's Syndrome)
06/2009 - 03/2009
2
Glioma (Gliomas)
02/2009 - 07/2007
2
Pulmonary Edema
10/2008 - 03/2005
2
Hypersensitivity (Allergy)
10/2008 - 03/2005
2
Cholestasis
01/2008 - 07/2006
2
Short Bowel Syndrome
01/2008 - 07/2006
2
Weight Loss (Weight Reduction)
10/2007 - 03/2004
2
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2007 - 09/2004
2
Hemorrhage
01/2006 - 03/2005
2
Hemangioma (Angioma)
12/2005 - 07/2005
2
Pulmonary Arterial Hypertension
12/2005 - 10/2004
1
Vision Disorders (Hemeralopia)
09/2013
1
Metabolic Diseases (Metabolic Disease)
09/2013
1
Diabetes Complications
09/2013
1
Colorectal Neoplasms (Colorectal Cancer)
06/2012
1
Duodenal Ulcer (Curling's Ulcer)
10/2011
Drug/Important Bio-Agent (IBA)
32
Angiogenesis Inhibitors
IBA
07/2011 - 10/2002
25
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2012 - 09/2002
14
Proteins (Proteins, Gene)
FDA Link
06/2012 - 09/2002
13
Endostatins
IBA
06/2012 - 09/2002
7
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
06/2012 - 09/2002
6
Angiostatins
IBA
10/2011 - 12/2002
6
O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)
IBA
04/2011 - 04/2003
6
Biomarkers (Surrogate Marker)
IBA
02/2008 - 07/2004
5
Matrix Metalloproteinases (MMPs)
IBA
10/2011 - 07/2005
5
Messenger RNA (mRNA)
IBA
06/2010 - 11/2003
5
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
05/2009 - 11/2002
4
Ligands
IBA
09/2010 - 10/2002
4
Pharmaceutical Preparations
IBA
07/2008 - 04/2003
3
Thrombospondin 1
IBA
09/2010 - 10/2006
3
Rosiglitazone (Avandia)
FDA Link
09/2010 - 10/2002
3
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
09/2010 - 02/2007
3
Celecoxib (Celebrex)
FDA Link
09/2010 - 07/2007
3
2-Methoxyestradiol
IBA
05/2010 - 02/2008
3
Peptides (Polypeptides)
IBA
04/2010 - 05/2003
3
Doxycycline (Periostat)
FDA Link
Generic
11/2009 - 06/2006
3
Tyrosine Kinase Inhibitors
IBA
05/2009 - 05/2007
3
ErbB Receptors (EGF Receptor)
IBA
05/2009 - 02/2008
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2008 - 04/2005
3
Thalidomide (Thalomid)
FDA Link
06/2008 - 06/2006
3
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
05/2008 - 04/2005
2
Insulin (Novolin)
FDA Link
09/2013 - 06/2008
2
Retinaldehyde (Retinal)
IBA
09/2013 - 10/2010
2
Platelet-Derived Growth Factor
IBA
06/2012 - 03/2009
2
Sunitinib (Sutent)
FDA Link
02/2012 - 05/2007
2
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
02/2012 - 03/2005
2
Tissue Inhibitor of Metalloproteinase-3
IBA
01/2012 - 02/2009
2
lodamin
IBA
04/2011 - 07/2008
2
salicylhydroxamic acid (SHAM)
IBA
04/2011 - 04/2003
2
Etoposide (VP 16)
FDA Link
Generic
09/2010 - 07/2007
2
Angiogenic Proteins
IBA
02/2010 - 07/2005
2
vandetanib (ZD6474)
IBA
05/2009 - 02/2008
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
05/2009 - 02/2008
2
matrigel
IBA
03/2009 - 01/2006
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
02/2009 - 02/2008
2
Thrombospondins
IBA
02/2009 - 01/2008
2
Bevacizumab (Avastin)
FDA Link
02/2008 - 07/2004
2
PPAR alpha
IBA
01/2008 - 02/2007
2
hydroxypropyl methacrylate
IBA
10/2007 - 03/2004
2
Imatinib Mesylate (Gleevec)
FDA Link
05/2007 - 09/2004
1
Platelet Factor 4
IBA
06/2012
1
HSP27 Heat-Shock Proteins
IBA
05/2012
1
Dietary Fats (Dietary Fat)
IBA
02/2012
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
02/2012
1
Eicosanoids
IBA
02/2012
1
Menhaden oil
IBA
02/2012
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
02/2012
1
Fatty Acids (Saturated Fatty Acids)
IBA
02/2012
1
Angiomotins
IBA
01/2012
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2012
1
Transforming Growth Factor alpha (TGF-alpha)
IBA
01/2012
1
MicroRNAs (MicroRNA)
IBA
01/2012
1
Transferrin (beta 2 Transferrin)
IBA
06/2011
1
Recombinant Proteins
IBA
06/2011
1
Conditioned Culture Media
IBA
06/2011
Therapy/Procedure
26
Therapeutics
09/2013 - 09/2002
8
Drug Therapy (Chemotherapy)
09/2010 - 11/2002
4
Radiotherapy
02/2010 - 11/2002
2
Transplantation
06/2010 - 11/2009
2
Aftercare (After-Treatment)
05/2008 - 02/2008
2
Parenteral Nutrition
01/2008 - 07/2006